{"id":965801,"date":"2026-05-21T08:07:38","date_gmt":"2026-05-21T12:07:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/"},"modified":"2026-05-21T08:07:38","modified_gmt":"2026-05-21T12:07:38","slug":"tvardi-therapeutics-to-participate-in-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/","title":{"rendered":"Tvardi Therapeutics to Participate in Upcoming Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p>HOUSTON, May  21, 2026  (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events:<\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat and 1-on-1 Meetings<br \/>Date: Thursday, June 4, 2026<br \/>Time: 8:10 AM ET<br \/>Location: New York, NY<\/p>\n<p>\n        <strong>Raymond James BioPharma CEO Strategy Series<\/strong><br \/>\n        <br \/>Format: Fireside Chat<br \/>Date: Friday, June 5, 2026<br \/>Time: 10:00 AM ET<br \/>Registration Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Kau6VmyQs7EzDrGgSbm7cEoPwRmHmHFdQdOckwd3cEmF7Q705QCVHYRBm-m7j6cqWAEPa7AS7O2IDh3bj7CkR-d37hPnx4DdIv2nG9RJaDvSuo9ciYOJFq6DjMMeJY3ZRZtceKoEJgd9H_U-reSFAtycsff7wxgRj0CY2oOW1JQfGxM1ZTU4TZgD7nzg6pGq_9SvK_vAhalYvTImqUzs8MQWgkoHB_NBIOAz28hdW_lk5Qtv1Jf-1Gzj-R2aMjo7usVIRmaNU0SA3Bql9Miyx5tI237zhl0Nsu-HOeAbpo0yCssW_Nr40XxynB378dFFkweU078k4VHGwrxL9yFnTY37hSBL1O_sZljasUgkho3_PR9Avl6EIAxf3xGMzFDGbbyy-T-YJdqlx-fmpidGIQjbA71UldRjWtL2ZLyBFpVMBJ_gRJxK72iOZ_weTFmJ8EflAKdoykC_GGinQbjJZsW-WqiXMN60FiZz00eYVz_5vFLfKq9RHjwF9b9_P2wxePtidC80NJiO1tyURfbpsJaOBurbsLuIhRLMjqkbdqGUP3gAf9aDaqCtqaxVtbfyCCtJCv1E6aVMW1DWsbSU3iLKlguflZzVcSrRIDI0sIohvTrNVkcb_2Xkfj4jHwKVMFpdtSX6zC6kqen5VqTymHMXiRnYlgYk83p0hgx7GBw=\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>The webcasts of the Jefferies and Raymond James fireside chats will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5egRm71_Lu1qzdY6IZILo7_ubKtw6kYng9iqzR3hgMDqDGvzhYXTnvhxIN0cimJ9B9meo1_SQ0b8niq_W9K_DP1HlJZEECUwIZyruUHVGAm2Aec-czDHZLcTQiF93qfm1xKe7GSwclFsPBTSUvHVs5Fzr07fGeZ-e2IBQj4Rlcxw8AQNQqoOItGilTHLiOj0B0r7sNtNMoH0ErJi3u9KOrxVDEyre0rSTD7G4aNBSkg6ed9Kz-CbMD1u6ZJ8c88bCvhMWcCZ6y2LrZryeIS7_fmlF5QwDhLJvsZ2CVa82grvCuvJOdfQpZqQrwzIvtGOvUw2UNRTD-rqEPikPtG1O5C_VVNTQFnA0CT03q6EbPQ9RrgeI3jhrJ73c8uMJCCWMNlYcTJphw-UZTNBWaViLcxwyYjTPD6253hi3CQnFqlz9e-x5S42b9e6Zi0KHPt_YsuvrREFczGtDLXZcTbe8VYv2Ahbl7vS2KrReuDl2zQ0PCUc31B7g0lAmo0V79xuVSE2eZp4IklYQk4_ZIk_ODv5DiEiuYsc8hUyAxlkWNSmCY3XQRqKROttykFJHGoWZpuMBF7ysFb0MwvVn1Oh6dKD8nwBh4VWaT2QFMyf-lSJuCOPc9GeZqcwqfZAWR12Py2Ah1SHEWr3tpA2R6dthTUDfarBH6iU_lFM77lDjtVHU3jZjRQyaWTrKdq6Inou\" rel=\"nofollow\" target=\"_blank\">Tvardi Investors\u2019 website<\/a>. A replay of the webcasts will be available for approximately 90 days following the conference.<\/p>\n<p>\n        <strong>About Tvardi Therapeutics<\/strong>\n      <\/p>\n<p>Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need. STAT3 is a central mediator across critical signaling pathways that drive uncontrolled proliferation, survival and immune dysregulation. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting clinical trials with TTI-109 in healthy volunteers and TTI-101 in hepatocellular carcinoma (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1R04LHvMsNnGva8ivUGB1BIzUFiYKfw7bZ35DsI881_ZjmvVe6GCqPAva5JcBZisA7F5A2KhRIptoziQIABARldwx44KguQtYHylQqpusVvrtcgZxmoiABycxDsBsAgdB4TDHzaG20Ms_aYq3deWE-WRxtH3eJ8wFDI0XTSLHb0wTm70urJA0DWARLABMDdDlgGncmPUmAA6PUBWxdybnjPf3H-KhP6jLbeWL7WjJbqAxwlXeo5W_9jQlvtMwiZ6xw7NNkVJykWztpZ5FPsVnPYGiwmVd2JaIQ8HVwLkqoc=\" rel=\"nofollow\" target=\"_blank\">NCT05440708<\/a>). To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=garoouPLafcZtRHc57rSGXTHnldEpR2C4v56qJOTt1gCKXAkeAGjHK1i4ovQ1q1w2YKAHsnxI-f0tR22sbQFd-tN3AvCWRhNtvKbhYSGAt38HMOIFyZI97jVH3JQ9px062mST1B1EARn98diDiFqXd48Tyh9tRHpNeliKYbFH54_YzYDi8BNUU7ASOYBG3iMBI8YvbST85YyGlHejR49DWdDqTEXa9T9sQXNAJw3l6YH0egIqw2jF8DcnOFVve4I21pZscyvy3hAMFGjEQwnRm5Ag8s2txdHnK0QR_KrV4A=\" rel=\"nofollow\" target=\"_blank\">tvarditherapeutics.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JhmFlYs3MZTAG11jnFn7YPQHoi2i0ind6aTJ-9nU6odIsdcyLA6uNt5e-PmL_uLVyEVpFoxp7cAK63jgPuyH49lKqt_o9oGhR14r5CXMo0eMCMk4gpO3vO8mkY8lYE9XEBSgRnEPkxDyVqrg6WTFL82r_c5tdLEwkL0RgFwML7wVGuyK_-WLblEIKHpIbYE2xlGZzCEe4RkyAeFX8rt_D2pSP3d1NSXJb3V9CE2pVOScMCOHp959cCQYE9t-fS-Glj2K2DAu53_szXjYlKQUyA==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ahu3x-KLRwUoxDOlAv0fJc2TG6rfrOkNEd0g1hJuiipQptIGF5wVoyZUgB0-Fuju-6pVQ-lGNsU6BWrtk260shwzmZu9qjYzluZNk68_AQNa9Mg1LZnNIVTLOr_n6QDKyZZVxlUsOrG6Nq-GxUm3l-FGB0nUFGaQ0Q4eueULLZaZy2V6gG94-ZWa8yr3hHVsXTTcPPZy9JSjKadmQ-Jljcoolz1rCbm33iNnkqutjeNWOjl1_HgGYhJGwcmn6NQl\" rel=\"nofollow\" target=\"_blank\">X (Twitter)<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>For Tvardi:<\/strong><br \/>\n        <br \/>Tvardi Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LFmDg_gfzvQcss_7akdCBFvvXwLcOr5p5Z2ri-4VLNAvqnmO_DPm4EGLBc1niSQY9xNkAZSg1fW3ckoSnEkduw==\" rel=\"nofollow\" target=\"_blank\">ir@tvardi.com<\/a><\/p>\n<p>PJ Kelleher<br \/>LifeSci Advisors<br \/>617-430-7579<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XBi4hgOaocFKULyzxl_tnEszT_Jd-XZd0Zavl_UL57rDm1m4oofh6WDBTxj_1aLPMHWR0p1_0N4GsRPaUB3ZCO9omXYZ-nlACvgREkSCmdczUf_Qj3GMQL9fwlDZxqv2\" rel=\"nofollow\" target=\"_blank\">pkelleher@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTlmY2JiMTUtYjYyNy00OTM2LTg3NzYtNzg4Mjc5NWEzYzAzLTUwMDEzMjg0Mi0yMDI2LTA1LTIxLWVu\/tiny\/Tvardi-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events: Jefferies Global Healthcare Conference Format: Fireside Chat and 1-on-1 MeetingsDate: Thursday, June 4, 2026Time: 8:10 AM ETLocation: New York, NY Raymond James BioPharma CEO Strategy Series Format: Fireside ChatDate: Friday, June 5, 2026Time: 10:00 AM ETRegistration Link: Here The webcasts of the Jefferies and Raymond James fireside chats will be accessible on the Tvardi Investors\u2019 website. A replay of the webcasts will be available for approximately 90 days following the conference. About Tvardi &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tvardi Therapeutics to Participate in Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-965801","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events: Jefferies Global Healthcare Conference Format: Fireside Chat and 1-on-1 MeetingsDate: Thursday, June 4, 2026Time: 8:10 AM ETLocation: New York, NY Raymond James BioPharma CEO Strategy Series Format: Fireside ChatDate: Friday, June 5, 2026Time: 10:00 AM ETRegistration Link: Here The webcasts of the Jefferies and Raymond James fireside chats will be accessible on the Tvardi Investors\u2019 website. A replay of the webcasts will be available for approximately 90 days following the conference. About Tvardi &hellip; Continue reading &quot;Tvardi Therapeutics to Participate in Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-21T12:07:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tvardi Therapeutics to Participate in Upcoming Investor Events\",\"datePublished\":\"2026-05-21T12:07:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/\",\"name\":\"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==\",\"datePublished\":\"2026-05-21T12:07:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tvardi Therapeutics to Participate in Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","og_description":"HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events: Jefferies Global Healthcare Conference Format: Fireside Chat and 1-on-1 MeetingsDate: Thursday, June 4, 2026Time: 8:10 AM ETLocation: New York, NY Raymond James BioPharma CEO Strategy Series Format: Fireside ChatDate: Friday, June 5, 2026Time: 10:00 AM ETRegistration Link: Here The webcasts of the Jefferies and Raymond James fireside chats will be accessible on the Tvardi Investors\u2019 website. A replay of the webcasts will be available for approximately 90 days following the conference. About Tvardi &hellip; Continue reading \"Tvardi Therapeutics to Participate in Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-21T12:07:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tvardi Therapeutics to Participate in Upcoming Investor Events","datePublished":"2026-05-21T12:07:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/","name":"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==","datePublished":"2026-05-21T12:07:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMzk3MiM3NjEzNjcyIzUwMDEzMjg0Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tvardi Therapeutics to Participate in Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=965801"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965801\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=965801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=965801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=965801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}